Cognitive impairment is both a core feature of schizophrenia spectrum disorders (SSDs; [@bb0040]), a vulnerability marker, and closely related to poor functional outcome and disability in SSDs ([@bb0100]). However, there is great variation in reported cognitive impairments in SSDs, and factors underlying this heterogeneity in cognitive functioning remain poorly understood. Risk factors influencing the development of SSDs may also potentially affect cognitive functioning directly or indirectly, such as illicit substance use which is a risk factor for psychosis, and has been found to influence cognitive vulnerability for psychosis ([@bb0130]).

Childhood trauma (CT), e.g. physical, sexual, emotional abuse and physical and emotional neglect ([@bb0025]) is another risk factor for SSDs ([@bb0155]) which may be associated with cognitive impairment. The association between CT and SSDs is evident across study designs and populations, and CT has been found to increase the risk of psychosis with an odds ratio of 2.8 ([@bb0245]). CT have been shown to have a detrimental effect on brain development and cognitive functioning in non-psychotic individuals, attributed to disrupted neurodevelopment and stress-regulating brain systems ([@bb0170]). Understanding the relationship between CT and cognition in SSDs may thus aid both its etiological understanding as well as treatment models for psychosis.

A handful of studies have found negative effects of CT on cognition in SSD patients. [@bb0205] found that CT in SSD predicted greater impairments in working memory and episodic memory as compared to SSD with no history of CT. [@bb0175] reported a negative association between CT and working memory performance in individuals with SSDs. However, some studies have failed to find an association between CT and cognitive impairment in SSDs (e.g. [@bb0165]). One study also indicated a positive effect of CT and cognitive abilities in SSDs ([@bb0185]).

One possible explanation for the observed variance of cognitive impairment in SSDs might be differential effects of various types of CT ([@bb0190]). [@bb0125] reported negative effects of physical abuse, neglect and sexual abuse on language and attention. [@bb0240] found physical CT to have a negative impact on cognitive function in individuals at ultra-high risk of psychosis.

In addition, the mixed findings on CT and cognitive impairment in SSDs could be attributed to discrepancies in the measurement of CT and the use of non-validated self-report questionnaires. The Childhood Trauma Questionnaire Short-Form (CTQ-SF; [@bb0020]) used in the present study is described as a reliable measure of CT in SSDs ([@bb0080]). Finally, sample differences between studies may also have contributed to the equivocal findings. For example, antipsychotic drug use has been found to improve cognition in SSDs ([@bb0095]).

In sum, findings on the relation between CT and cognitive impairment in SSDs are inconclusive, and few studies to date have examined whether CT subtypes might differentially affect cognitive functioning in SSDs. The aim of the present study is therefore to investigate possible effects of CT and CT subtypes on global cognitive performance and specific cognitive domains in a clinically representative sample of patients with SSDs.

1. Methods and material {#s0005}
=======================

The present study is based on cross-sectional data from the Bergen Psychosis project 2 (BP2), Haukeland University Hospital, Bergen, Norway. The BP2 is an independently funded multi-site prospective study including a randomized, rater-blind, head-to-head comparison of amisulpride, aripiprazole, and olanzapine, approved by the Regional Committee for Medical Research Ethics (2010--3387) and registered as a clinical trial 10/03/2011 ([www.clinicaltrials.gov](http://www.clinicaltrials.gov){#ir0005}: [NCT01446328](NCT01446328){#ir0010}). Inclusion/exclusion criteria for the BP2 have been described elsewhere ([@bb0160]). The current sample consisted of 78 patients with SSDs, 49 (63.6%) male, mean age 29.8 years (*SD* = 12.4 years; [Table 1](#t0005){ref-type="table"}).Table 1Mean (SD) clinical and demographic characteristics by CT/no CT group.Table 1No CT (*n* = 37)CT (*n* = 41)Total (*n* = 78)*t*/*χ*^2^*p*-ValueAge29.46 (11.97)30.20 (12.87)29.84 (12.37)−0.260.795Gender Male28 (57.14%)21 (42.86%)49 (62.80%)4.980.026\* Female9 (31.03%)20 (68.97%)29 (37.20%)Duration of illness (*n* = 70)5.99 (10.71)5.30 (5.99)5.63 (8.55)0.330.737Duration of untreated psychosis (*n* = 58)26 (36.87)83.06 (132.35)55.52 (101.90)−2.200.032Antipsychotics DDD1.18 (0.51)1.13 (0.80)1.30 (0.75)0.340.736Years of education13 (2.79)11.88 (2.67)12.41 (2.76)1.820.073Education Primary14 (42.42%)19 (57.58%)33 (42.3%)0.730.392 Further23 (52.27%)21 (47.73%)44 (57.14%)Civil status Single30 (49.18%)31 (50.82%)61 (91%)0.670.414 Married/divorced4 (66.67%)2 (33.33%)6 (9%)Living situation Independently20 (47.62%)22 (52.38%)42 (54.55%)1.090.578 Supported housing/institution16 (42.11%)18 (47.37%)34 (44.16%) No residence1 (100%)0 (0%)1 (1.30%)PANSS baseline (*n* = 77) Positive symptoms18.54 (5.59)21.38 (5.30)20.01 (5.59)−2.280.025\* Negative symptoms15.84 (6.38)19.05 (6.33)17.51 (6.51)−2.220.029\* General psychopathology scale36.41 (11.34)39.40 (7.66)37.96 (9.66)−1.370.175 Total70.78 (20.89)79.83 (14.79)75.48 (18.43)−2.210.029\*DUDIT (*n* = 54)12.73 (12.57)9.34 (11.92)10.97 (12.24)1.020.313AUDIT (*n* = 68)9.10 (6.46)8.19 (6.43)8.63 (6.41)0.590.559CTQ-SF Emotional abuse6.46 (1.94)12.85 (5.24)9.82 (5.13)−7.000.001\* Physical abuse5.22 (0.53)7.24 (3.63)6.28 (2.83)−3.370.001\* Sexual abuse5.05 (0.33)7.34 (4.25)6.28 (3.28)−3.260.001\* Emotional neglect7.73 (2.62)14.95 (5.58)11.52 (5.71)−7.180.001\* Physical neglect6.24 (1.46)9.48 (3.67)9.95 (3.26)−5.030.001\* Sum30.70 (3.99)51.88 (14.21)41.83 (15.02)−8.750.001\*Cognitive domains Verbal abilities (*n* = 76)49.35 (9.54)45.64 (9.13)47.39 (9.45)1.730.087 Visuospatial abilities46.73 (10.18)44.39 (9.78)45.50 (9.97)1.030.306 Learning43.63 (7.35)42.21 (7.50)42.88 (7.42)0.850.400 Memory46.03 (6.99)43.15 (8.84)44.52 (8.10)1.580.116 Attention/working memory44.20 (6.47)42.39 (8.84)43.25 (7.81)1.020.309 Executive abilities (*n* = 75)48.97 (10.99)45.29 (12.09)47.05 (11.65)1.380.173 Processing speed43.59 (8.05)40.75 (10.03)42.10 (9.19)1.370.175 Global cognitive performance46.20 (6.39)43.45 (7.59)44.76 (7.13)1.690.095[^1]

Participants were recruited at the Medical University in Innsbruck, Innsbruck, Austria (*n* = 10); Stavanger University Hospital, Stavanger, Norway (*n* = 8); and Haukeland University Hospital, Bergen, Norway (*n* = 60), and gave informed consent to participate.

Participants were required to meet diagnostic criteria for SSDs in the range F20--29 of the ICD-10 ([@bb0260]): F20 Schizophrenia (*n* = 44), F21 Schizotypal disorder (*n* = 2), F22 Persistent delusional disorder (*n* = 7), F23 Acute and transient psychotic disorders (*n* = 11), F25 Schizoaffective disorder (*n* = 5), or F29 Unspecified nonorganic psychosis (*n* = 9), as determined by the Structural Clinical Interview for Axis I Disorders (SCID; [@bb0225]), be \>18 years of age, be able to read, understand and speak the native language, and score ≥ 4 on at least one of the following items on the Positive and Negative Syndrome Scale (PANSS; [@bb0105]): Delusions (P1), hallucinatory behavior (P3), grandiosity (P5), suspiciousness/persecution (P6) or unusual thought content (G9). Exclusion criteria were organic psychosis or psychosis due to substance use.

2. Measurement {#s0010}
==============

2.1. Childhood trauma {#s0015}
---------------------

The CTQ-SF is a 28-item self-report questionnaire screening for five subtypes of childhood trauma: childhood sexual, physical and emotional abuse, and physical and emotional neglect ([@bb0025]). Each subscale consists of five items scored on a five-point Likert scale ranging from 1 (*never true*) to 5 (*very often true*), summarized into an overall CTQ-SF sum score ranging from 25 to 125. Three items make up the Minimization-denial subscale. The CTQ-SF has shown good internal consistency, test-retest reliability, and excellent internal reliability, as well as good sensitivity and specificity ([@bb0070]). For the present study, the overall reliability estimate for the CTQ-SF was high: Cronbach\'s *α* = 0.91. Subscale Cronbach\'s *α* were: Emotional abuse = 0.88, physical abuse = 0.80, sexual abuse = 0.91, emotional neglect = 0.92, and physical neglect = 0.60.

2.2. Cognitive assessment {#s0020}
-------------------------

Trained research nurses performed the cognitive assessments: a three-hour comprehensive test battery. The following seven domains of cognition were assessed: 1) verbal abilities; 2) visuospatial abilities; 3) verbal learning; 4) memory (long-term memory and recognition); 5) attention/working memory; 6) executive abilities and 7) processing speed.

Verbal abilities were assessed by the Wechsler Adult Intelligence Scale III (WAIS III; [@bb0250]) subtests vocabulary and similarities subtests, and the Delis-Kaplan Executive Function System (D-KEFS) verbal fluency test ([@bb0065]). Visuospatial abilities were assessed by the WAIS III subtests block design and digit symbol-coding, as well as the Rey-Osterrieth Complex Figure Test ([@bb0210]). Learning was assessed by the California verbal learning test (CVLT; [@bb0060]) i.e. trials 1--5, and the digit span subtest of the WAIS III. Memory was assessed by the CVLT (subtests short delay free and cued recall, long delay free and cued recall, and delayed recognition) and Rey-Osterrieth Complex Figure Test ([@bb0210]). Attention and working memory were assessed by the Digit vigilance test ([@bb0120]), the CALCAP Continuous Performance Test subtests sequential reaction time and choice reaction time ([@bb0145]), Trail Making Test (TMB; [@bb0180]), the WAIS III subtests digit span and letter-number sequencing, and the Wechsler Memory Scale ([@bb0250]). Executive abilities were measured using the Wisconsin Card Sorting test ([@bb0090]) and the Stroop test ([@bb0230]). Processing speed was measured using the TMA ([@bb0180]), the digit symbol-coding subtest of the WAIS III, the Grooved Pegboard Test ([@bb0035]), and the CALCAP subtest simple reaction time ([@bb0045]).

The study included well-validated and reliable cognitive measures commonly used in studies of cognitive functioning in individuals with SSDs: The Wechsler Memory Scale ([@bb0250]) was found to be a reliable measure of memory deficits in schizophrenia ([@bb0085]). The WAIS III is described as having good psychometric properties ([@bb0220]). The Delis Kaplan Executive Function System (D-KEFS) ([@bb0065]) was found to have good psychometric properties ([@bb0215]), as did the TMT Part A and B ([@bb0030]; [@bb0065]), the Grooved Pegboard Test ([@bb0075]) and the Rey-Osterrieth Complex Figure Test ([@bb0210]). The CVLT ([@bb0060]) is described as reliable and valid ([@bb0265]). The CALCAP Continuous performance test was found to possess adequate psychometric properties ([@bb0145]). [@bb0115] report promising reliability data for the Wisconsin Card Sorting test ([@bb0090]).

Raw scores from cognitive tests were converted to standardized t-scores based on the best available norms (corrected for age, but not for gender and education). Cognitive domain t-scores were calculated as the mean t-score across tests for each domain. A global cognitive performance t-score was calculated by averaging the t-scores from every test.

2.3. Other measurements {#s0025}
-----------------------

The use of antipsychotic drugs at the time of neurocognitive testing was converted to Defined Daily Doses (DDD) as given by the World Health Organization Collaborating Centre for Drug Statistics Methodology at the Norwegian Institute of Public Health ([www.whocc.no](http://www.whocc.no){#ir0015}). The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. Adherence with medication was assessed by means of serum level measurements of antipsychotic drugs.

2.4. Procedure {#s0030}
--------------

Patients included in BP 2 were assessed at baseline, week 1, 3, 6, 12, 26, 39 and 52. The CTQ-SF was administered at the 6-weeks. The PANSS was measured at week 1, and the cognitive test battery at the 12-week follow-up.

2.5. Statistical analyses {#s0035}
-------------------------

All analyses were carried out using STATA. Measures are presented as means (*M*) and standard deviations (*SD*), or as number (*n*) and percentages (*%*). A *p*-level of *\<*.05 was considered statistically significant, except for in the regression analyses where we corrected for multiple testing by means of a Bonferroni adjustment (0.05/40 = *p* \< .00125). Missing data were handled through imputation based on expectation maximation, and the amount of missing data in the CTQ-SF scale was 0.73%.

CTQ-SF scores were categorized into none, low, moderate and severe abuse or neglect, based on threshold scores in the CTQ-SF manual. A dichotomous variable was created, grouping none and low levels of CT (meaning CT absent) on the one hand, and moderate and severe levels (CT present) on the other ([@bb0015]). The sample was divided into two groups: Participants reporting CT (*n* = 41), and participants with no CT experiences (*n* = 37). The relation between demographic variables and CT/no CT-groups was investigated using independent sample *t*-tests, non-parametric Mann-Whitney *U* test, or *χ*^*2*^ tests. Significant results in these tests determined the inclusion of that variable in the regression models to control for confounders. Antipsychotics was included based on previous research showing effect on cognition in SSDs receiving antipsychotic treatment ([@bb0095]).

For the linear regression analyses, CTQ-SF subscale scores (5--25) were used as predictors for the cognitive performance scores. The first analyses used CTQ-SF subscales as predictors for the cognitive domains. Then, we included gender, PANSS positive and negative symptom scales, and antipsychotic medication (DDD) as confounders. Due to multicollinearity, the PANSS total score was omitted from the analyses. In the last model, we controlled for years of education if this was not already corrected for in the test scoring norms. All scoring norms were corrected for age.

The goodness of fit as measured by adjusted *R*^2^ (*R*^2^~a~) is assessed as small if ≤0.09, moderate between 0.1 and 0.3 and large effect if ≥0.3 ([@bb0140]). We visually inspected frequency distributions of variables for normality. All regression models were tested for, and adhered to, the assumptions underlying linear multiple regression.

3. Results {#s0040}
==========

3.1. Demographic and clinical data {#s0045}
----------------------------------

When examining the CTQ-SF, we found that 21 of 78 (26.9%) patients with SSDs reported emotional abuse, 8 of 78 (10.3%) reported physical abuse, 12 of 78 (15.4%) reported sexual abuse, 23 of 78 (29.5%) reported emotional neglect and 20 of 78 (25.6%) reported physical neglect (according to the cut-off of moderate to severe level of abuse and neglect). Further, 37 (47.4%) patients reported no CT, and 41 (52.6%) patients reported 1--5 CT.

We tested for gender differences between CT/no CT groups, and found that the majority of male participants reported no CT, whereas the majority of the female participants reported CT experiences. This difference was statistically significant ([Table 1](#t0005){ref-type="table"}). We also found that the CT group reported significantly higher levels of positive and negative psychosis symptoms compared to the no CT group ([Table 1](#t0005){ref-type="table"}). There were no other significant effects of demographic and clinical data on CT/no CT groups. Further, serum levels generally corresponded well with the antipsychotic drug doses (DDD), indicating satisfactory adherence with medication.

Mean (SD) median, skewness and kurtosis was the following for cognitive domains: Global cognitive performance 44.76 (7.13) 45.26, −0.24 and 2.55; verbal abilities 47.39 (9.45) 46.12, 0.41 and 2.76; visuospatial abilities 45.50 (9.98) 45.88, −0.30 and 2.40; learning 42.89 (7.41) 41.88, −0.02 and 3.51; memory 44.52 (8.10) 43.84, −0.77 and 4.25; attention/working 43.25 (7.81) 42.89, −0.03 and 2.77; executive abilities 47.05 (11.65) 47.5, −0.51 and 3.23; processing speed 42.10 (9.19) 43.25, −0.34 and 3.13. The values were assessed as satisfactory.

3.2. Comparison of cognitive performance in SSDs by CT/no CT groups {#s0050}
-------------------------------------------------------------------

We compared cognitive performance in two groups of SSDs patients; one group with no CT, compared to those reporting CT experiences There were no statistically significant differences in global cognitive performance between CT/no CT groups (*p* = .095), nor in verbal abilities (*p* = .087), visuospatial abilities (*p* = .306), learning (*p* = .400), memory (*p* = .116), attention/working memory (*p* = .309), executive abilities (*p* = .173) or processing speed (*p* = .175; [Table 1](#t0005){ref-type="table"} and [Fig. 1](#f0005){ref-type="fig"}).Fig. 1Cognitive performance by cognitive domain grouped by CT.Note. *N* = 78, except verbal abilities (*n* = 76) and executive abilities (*n* = 75). CT = moderate to severe childhood trauma. Bonferroni adjusted *p*-level of .00125. No significant results. Verbal abilities: Wechsler Adult Intelligence Scale III (WAIS III; [@bb0250]) subtests vocabulary and similarities subtests, and the D-KEFS verbal fluency test ([@bb0065]). Visuospatial abilities: Block design and digit symbol-coding subtests of WAIS III, as well as the Rey-Osterrieth Complex Figure Test ([@bb0210]). Learning: California verbal learning test (CVLT; [@bb0060]) trials 1--5, and the digit span subtest of the WAIS III. Memory: CVLT (subtests short delay free and cued recall, long delay free and cued recall, and delayed recognition) and Rey-Osterrieth Complex Figure Test ([@bb0210]). Attention/working memory: Digit vigilance test ([@bb0120]), the CalCAP Continuous performance test subtests sequential reaction time and choice reaction time ([@bb0045]), Trail Making Test (Part B) ([@bb0180]), the WAIS III subtests digit span and letter-number sequencing, and the Wechsler Memory Scale ([@bb0250]). Executive abilities: Wisconsin Card Sorting test ([@bb0090]) and the Stroop test ([@bb0230]). Processing speed: Trail Making Test (Part A) ([@bb0180]), the digit symbol-coding subtest of the WAIS III, the Grooved Pegboard Test ([@bb0035]), and the CalCAP subtest simple reaction time ([@bb0045]).Fig. 1

3.3. The association of CT subtypes on cognitive performance {#s0055}
------------------------------------------------------------

In the first linear regression models, we tested for the effect of CT subtypes on cognitive performance in SSDs. The analyses showed statistically significant effects for the regression models (CT subtypes as predictors) on global cognitive performance, *F*(5, 69) = 3.14, *p* = .013, adjusted *R*^2^ (*R*^2^~a~) = 0.13, visuospatial abilities, *F*(5, 72) = 2.99, *p* = .016, *R*^2^~a~ = 0.11, learning, *F*(5, 72) = 2.76, *p* = .024, *R*^2^~a~ = 0.10, memory, *F*(5, 72) = 3.32, *p* = .009, *R*^2^~a~ = 0.13, attention and working memory, *F*(5, 72) = 4.90, *p* \< .001, *R*^2^~a~ = 0.20, and processing speed, *F*(5, 72) = 2.61, *p* = .031, *R*^2^~a~ = 0.10. Goodness of fit for the models was small to moderate. No significant effects were found for the CT subtypes and verbal abilities (*p* = .131) and executive functioning (*p* = .419).

After correcting for multiple comparisons (Bonferroni adjustment 0.05/40 = *p* \< .00125), the results indicated that the association between the predictors and cognitive impairment in SSDs is mainly driven by physical neglect in predicting impairment in global cognitive performance (*p* \< .001), visuospatial abilities (*p* \< .001), attention/working memory (*p* \< .001) and memory (*p* \< .001; [Table 2](#t0010){ref-type="table"}).Table 2The effects of CTQ-SF subtypes on cognition by cognitive domain.Table 2Global cognitive performanceVerbal abilitiesVisuospatial abilitiesLearningMemoryAttention/working memoryExecutive abilitiesVisuomotor processing speedEmotional abuse−0.1340.0960.026−0.1430.088−0.227−0.222−0.444(−0.58)(0.30)(0.08)(−0.61)(0.35)(−0.98)(−0.57)(−1.53)Physical abuse0.007−0.4830.2540.096−0.1460.0650.7470.280(0.02)(−0.77)(0.43)(0.21)(−0.31)(0.15)(0.99)(0.50)Sexual abuse0.152−0.02650.014−0.0840.2330.021−0.1910.242(0.48)(−0.06)(0.03)(−0.27)(0.69)(0.07)(−0.36)(0.62)Emotional neglect0.348−0.02810.3430.416[⁎](#tf0005){ref-type="table-fn"}0.2610.511[⁎⁎](#tf0010){ref-type="table-fn"}0.3340.444(1.84)(−0.11)(1.35)(2.18)(1.28)(2.70)(1.05)(1.88)Physical neglect−1.288[⁎⁎⁎](#tf0015){ref-type="table-fn"}−1.013[⁎](#tf0005){ref-type="table-fn"}−1.560[⁎⁎⁎](#tf0015){ref-type="table-fn"}−1.027[⁎⁎](#tf0010){ref-type="table-fn"}−1.243[⁎⁎⁎](#tf0015){ref-type="table-fn"}−1.342[⁎⁎⁎](#tf0015){ref-type="table-fn"}−1.182[⁎](#tf0005){ref-type="table-fn"}−1.142[⁎⁎](#tf0010){ref-type="table-fn"}(−4.12)(−2.21)(−3.72)(−3.27)(−3.70)(−4.31)(−2.13)(−2.92)Constant50.8658.4052.0147.5850.0149.7151.2247.14(20.21)(15.91)(15.40)(18.82)(18.50)(19.81)(11.57)(14.97)*N*7576787878787578[^2][^3][^4][^5]

3.4. The association of CT subtypes on cognitive performance controlling for gender and psychosis symptoms {#s0060}
----------------------------------------------------------------------------------------------------------

We tested for the effect of CT subtypes on cognitive performance in SSDs and controlled for gender, positive and negative psychosis symptoms, and antipsychotic medication.

The analyses showed statistically significant effects for the regression models based on the predictors (CT subtypes, gender, psychosis symptoms, antipsychotics) on global cognitive performance, *F*(9, 62) = 2.95, *p* = .005, *R*^2^~a~ = 0.19, visuospatial abilities, *F*(9, 65) = 2.67, *p* = .010, *R*^2^~a~ = 0.16, learning, *F*(9, 65) = 2.65, *p* = .011, *R*^2^~a~ = 0.16, memory, *F*(9, 65) = 3.75, *p* \< .001, *R*^2^~a~ = 0.25, and attention and working memory, *F*(9, 65) = 3.60, *p* = .001, *R*^2^~a~ = 0.24, and processing speed, *F*(9, 65) = 3.57, *p* \< .001, *R*^2^~a~ = 0.24. Goodness of fit for the models (*R*^2^~a~) was assessed as small to moderate. No significant effects were found for the CT subtypes and executive functioning (*p* = .636) and verbal abilities (*p* = .122).

After correcting for multiple comparisons (Bonferroni adjustment 0.05/40 = *p* \< .00125), the results indicate that the association between the predictors and cognitive impairment in SSDs is mainly driven by the CT subtype physical neglect (see [Table 3](#t0015){ref-type="table"}). Increase in reported physical neglect predicted more impairment in attention/working memory abilities (*p* \< .001; [Table 3](#t0015){ref-type="table"}).Table 3The effects of CTQ-SF subtypes on cognition by cognitive domain, controlling for antipsychotics, gender and psychosis symptoms.Table 3Global cognitive performanceVerbal abilitiesVisuospatial abilitiesLearningMemoryAttention/working memoryExecutive abilitiesProcessing speedEmotional abuse0.2020.1620.428−0.03890.3400.03550.2230.147(0.85)(0.46)(1.22)(−0.16)(1.27)(0.14)(0.49)(0.50)Physical abuse−0.223−0.772−0.132−0.239−0.502−0.2860.615−0.216(−0.54)(−1.26)(−0.22)(−0.56)(−1.09)(−0.67)(0.77)(−0.43)Sexual abuse−0.05050.00466−0.0631−0.05770.231−0.0457−0.402−0.00674(−0.17)(0.01)(−0.15)(−0.19)(0.71)(−0.15)(−0.71)(−0.02)Emotional neglect0.1980.05670.1840.437[⁎](#tf0020){ref-type="table-fn"}0.2390.427[⁎](#tf0020){ref-type="table-fn"}0.05470.114(1.02)(0.20)(0.65)(2.18)(1.10)(2.11)(0.15)(0.48)Physical neglect−1.001[⁎⁎](#tf0025){ref-type="table-fn"}−0.797−1.328[⁎⁎](#tf0025){ref-type="table-fn"}−0.730[⁎](#tf0020){ref-type="table-fn"}−0.994[⁎⁎](#tf0025){ref-type="table-fn"}−1.082[⁎⁎⁎](#tf0030){ref-type="table-fn"}−1.009−0.947[⁎⁎](#tf0025){ref-type="table-fn"}(−3.31)(−1.79)(−3.15)(−2.44)(−3.07)(−3.59)(−1.74)(−2.69)Gender0.7312.986−0.4261.7340.1450.749−1.0311.644(0.45)(1.26)(−0.18)(1.05)(0.08)(0.45)(−0.33)(0.84)PANSS positive0.1090.2870.1230.0617−0.03990.07210.06100.145(0.78)(1.38)(0.59)(0.42)(−0.25)(0.49)(0.23)(0.84)PANSS negative−0.211−0.405−0.227−0.319[⁎](#tf0020){ref-type="table-fn"}−0.410[⁎⁎](#tf0025){ref-type="table-fn"}−0.1300.0151−0.00123(−1.49)(−1.94)(−1.14)(−2.26)(−2.69)(−0.91)(0.06)(−0.01)Antipsychotics DDD−2.448[⁎](#tf0020){ref-type="table-fn"}−0.500−3.435[⁎](#tf0020){ref-type="table-fn"}−1.594−1.648−2.825[⁎](#tf0020){ref-type="table-fn"}−2.438−5.129[⁎⁎⁎](#tf0030){ref-type="table-fn"}(−2.34)(−0.32)(−2.22)(−1.46)(−1.39)(−2.56)(−1.21)(−3.98)Constant54.7657.2857.2652.0658.2053.2853.2551.71(15.74)(11.17)(11.72)(15.04)(15.52)(15.26)(7.98)(12.68)*N*7273757575757275[^6][^7][^8][^9]

Lastly, we performed the analyses including education as a predictor for the cognitive domains. The analyses showed statistically significant effects for the regression models based on the predictors (CT subtypes, gender, psychosis symptoms, antipsychotics and education) on global cognitive performance, *F*(10, 61) = 4.59, *p* \< .001, *R*^2^~a~ = 0.33, verbal abilities, *F*(10, 62) = 3.42, *p* \< .001, *R*^2^~a~ = 0.25, visuospatial abilities, *F*(10, 64) = 5.05, *p* \< .001, *R*^2^~a~ = 0.35, learning, *F*(10, 64) = 4.34, *p* \< .001, *R*^2^~a~ = 0.31, memory, *F*(10, 64) = 5.85, *p* \< .001, *R*^2^~a~ = 0.40, attention and working memory, *F*(9, 65) = 3.60, *p* \< .001, *R*^2^~a~ = 0.24, and processing speed, *F*(9, 65) = 3.57, *p* \< .001, *R*^2^~a~ = 0.23. Goodness of fit for the models (*R*^2^~a~) was assessed as moderate to large. No significant effects were found for the CT subtypes and executive functioning (*p* = .722).

After correcting for multiple comparisons (Bonferroni adjustment 0.05/40 = *p* \< .00125), the results indicate that the association between the predictors and cognitive impairment in SSDs is mainly driven by the CT subtype physical neglect (see [Table 4](#t0020){ref-type="table"}). Increase in reported physical neglect predicted more impairment in attention/working memory abilities (*p* \< .001; [Table 4](#t0020){ref-type="table"}).Table 4The effects of CTQ-SF subtypes on cognition by cognitive domain, controlling for antipsychotics, education, gender and psychosis symptoms.Table 4Global cognitive performanceVerbal abilitiesVisuospatial abilitiesLearningMemoryAttention/working memoryExecutive abilitiesProcessing speedEmotional abuse0.1920.1470.432−0.03600.3440.03550.2230.147(0.88)(0.46)(1.40)(−0.16)(1.42)(0.14)(0.49)(0.50)Physical abuse−0.310−0.909−0.312−0.351−0.631−0.2860.615−0.216(−0.82)(−1.64)(−0.59)(−0.91)(−1.52)(−0.67)(0.77)(−0.43)Sexual abuse0.1580.3230.3010.1710.493−0.0457−0.402−0.00674(0.57)(0.80)(0.79)(0.61)(1.65)(−0.15)(−0.71)(−0.02)Emotional neglect0.124−0.04770.05920.3590.1490.427[⁎](#tf0035){ref-type="table-fn"}0.05470.114(0.70)(−0.18)(0.24)(1.95)(0.76)(2.11)(0.15)(0.48)Physical neglect−0.769[⁎⁎](#tf0040){ref-type="table-fn"}−0.452−0.994[⁎](#tf0035){ref-type="table-fn"}−0.520−0.754[⁎](#tf0035){ref-type="table-fn"}−1.082[⁎⁎⁎](#tf0045){ref-type="table-fn"}−1.009−0.947[⁎⁎](#tf0040){ref-type="table-fn"}(−2.72)(−1.10)(−2.62)(−1.87)(−2.54)(−3.59)(−1.74)(−2.69)Gender0.6643.010−0.5231.6730.07540.749−1.0311.644(0.45)(1.41)(−0.25)(1.11)(0.05)(0.45)(−0.33)(0.84)PANSS positive0.03370.1680.000714−0.0151−0.1280.07210.06100.145(0.26)(0.89)(0.00)(−0.11)(−0.89)(0.49)(0.23)(0.84)PANSS negative−0.149−0.317−0.144−0.267[⁎](#tf0035){ref-type="table-fn"}−0.350[⁎](#tf0035){ref-type="table-fn"}−0.1300.0151−0.00123(−1.15)(−1.67)(−0.82)(−2.07)(−2.54)(−0.91)(0.06)(−0.01)Antipsychotics DDD−2.081[⁎](#tf0035){ref-type="table-fn"}0.0694−2.739[⁎](#tf0035){ref-type="table-fn"}−1.156−1.147−2.825[⁎](#tf0035){ref-type="table-fn"}−2.438−5.129[⁎⁎⁎](#tf0045){ref-type="table-fn"}(−2.17)(0.05)(−2.00)(−1.15)(−1.07)(−2.56)(−1.21)(−3.98)Education0.925[⁎⁎⁎](#tf0045){ref-type="table-fn"}1.445[⁎⁎⁎](#tf0045){ref-type="table-fn"}1.570[⁎⁎⁎](#tf0045){ref-type="table-fn"}0.989[⁎⁎⁎](#tf0045){ref-type="table-fn"}1.131[⁎⁎⁎](#tf0045){ref-type="table-fn"}(3.72)(3.99)(4.42)(3.81)(4.08)Constant41.5736.9035.4738.3442.5053.2853.2551.71(8.75)(5.36)(5.42)(8.01)(8.31)(15.26)(7.98)(12.68)*N*7273757575757275[^10][^11][^12][^13]

4. Discussion {#s0065}
=============

Reported levels of childhood physical neglect in our sample of SSDs predicted significant impairment in cognitive performance in attention/working memory abilities after adjusting for multiple comparisons, and controlling psychosis symptoms, antipsychotics, years of education, age and gender. In contrast, we found no significant differences in cognitive functioning between CT and no CT groups, nor between any other subtype of CT and the studied cognitive domains. Our findings regarding physical neglect indicate that CT subtypes might differentially influence cognitive abilities.

Half of our sample of patients with SSDs reported experiences of moderate to severe CT. Of those reporting CT, the majority had experienced up to three subtypes of CT. This is in line with previous studies on CT in SSDs ([@bb0135]), and reports of co-occurrence of types of CT ([@bb0110]). Our findings regarding associations between reports of CT and cognitive impairment, are in agreement with previous reports ([@bb0175]; [@bb0205]). We did not find all types of CT to predict cognitive impairment in our sample of SSDs. This may in part explain inconsistency in previous research ([@bb0050]): While some studies report associations between CT and cognitive impairment in SSDs ([@bb0005]), others, e.g. [@bb0185], did not find early trauma to predict cognitive impairment. Our findings indicate that CT subtype physical neglect may in part explain these discrepancies.

[@bb0190] suggested that some of the variance in cognitive impairment in SSDs could be explained by subtype of CT, as demonstrated by our findings that physical neglect is more closely associated with poorer cognitive performance. Our findings are in line with reports such as [@bb0125], whom in a sample of patients with SSDs found an association between physical neglect and impaired attention and memory, Traditionally, research has mainly focused on sexual and physical abuse ([@bb0055]). Although childhood neglect is frequently reported, the neurocognitive effects of neglect are understudied ([@bb0055]). As neglect entails an inability to meet basic emotional and physical needs, including nutrition and proper medical care during illness, and is related to other forms of abuse, the adverse neurocognitive consequences could be more extensive than for other types of abuse ([@bb0255]). [@bb0150] found physical and emotional neglect to be negatively related to cognitive measures and report preliminary evidence for a role of early neglect in disrupted development of prefrontal cortex (PFC) connectivity and disturbed myelination regulation in SSDs. Early neglect at 3 years was found to predict hair cortisol concentration (HCC) in a transdiagnostic group ([@bb0200]). HCC indicates cumulative cortisol levels associated with long term stress-reactions, indicating altered HPA-axis biology following inadequate care ([@bb0200]). Thus, the absence of a reliable caregiver could be associated with negative impact on the developing brain ([@bb0055]) due to disrupting normative brain development during sensitive periods ([@bb0195]), possibly affecting cognitive functioning in adulthood. Childhood neglect could thus be characterized as an impoverished parent-child relationship, which may in turn be a marker of an inherited cognitive vulnerability compounded by a gene-environment interaction, thus increasing psychopathology ([@bb0195]). Maltreated and neglected children are also more likely to have parents who were themselves maltreated or traumatized, indicating intergenerational transmission involving maltreatment and neglect, deficient parenting skills, family stressors and genetic and epigenetic risk ([@bb0235]).

When interpreting our findings, our limited sample size should be taken into account, as this boosts the risk of a Type II error. We did not use a control group in the present study, limiting knowledge on how levels of CT and cognitive performance compare to participants without SSDs. We were unable to control for cannabis use, socio-economic status or parental cognitive functioning, known to influence cognitive impairment in SSDs ([@bb0255]; [@bb0130]). CT is measured retrospectively and by self-report, which might be associated to problems with validity and reliability. However, retrospective measurement of CT in SSDs is indicated to be valid and reliable ([@bb0080]), albeit afflicted with common problems of retrospective self-reported methods of measuring CT ([@bb0010]).

Strengths of the study are the large clinical cognitive test-battery used, and the CTQ-SF is a well validated measure of CT, which allowed us to better differentiate between subtypes than much of the previous literature using other measures. Future research could benefit from a longitudinal design, with CT measured more close in time to the trauma and with additional measures to self-report.
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[^1]: Note. N = 78 if not stated otherwise. Continuous variables analyzed using independent samples *t*-test, and categorical variables analyzed using χ2. Duration of untreated psychosis in weeks, and duration of illness in years. DDD = defined daily dose, PANSS = The Positive and Negative Syndrome Scale, CTQ-SF = Childhood Trauma Questionnaire Short Form, AUDIT = Alcohol Use Disorder Identification Test, DUDIT = Drug Use Disorder Identification Test. \* significant at *p* \< .05. Verbal abilities: Wechsler Adult Intelligence Scale III (WAIS III; [@bb0250]) subtests vocabulary and similarities subtests, and the D-KEFS verbal fluency test ([@bb0065]). Visuospatial abilities: Block design and digit symbol-coding subtests of WAIS III, as well as the Rey-Osterrieth Complex Figure Test ([@bb0210]). Learning: California verbal learning test (CVLT; [@bb0060]) trials 1--5, and the digit span subtest of the WAIS III. Memory: CVLT (subtests short delay free and cued recall, long delay free and cued recall, and delayed recognition) and Rey-Osterrieth Complex Figure Test ([@bb0210]). Attention/working memory: Digit vigilance test ([@bb0120]), the CalCAP Continuous performance test subtests sequential reaction time and choice reaction time ([@bb0045]), Trail Making Test (Part B) ([@bb0180]), the WAIS III subtests digit span and letter-number sequencing, and the Wechsler Memory Scale ([@bb0250]). Executive abilities: Wisconsin Card Sorting test ([@bb0090]) and the Stroop test ([@bb0230]). Processing speed: Trail Making Test (Part A) ([@bb0180]), the digit symbol-coding subtest of the WAIS III, the Grooved Pegboard Test ([@bb0035]), and the CalCAP subtest simple reaction time ([@bb0045]).

[^2]: Note. Numbers are regression coefficients, and *t-*statistics in parenthesis. Constant = The value of the dependent variable holding all predictors constant. PANSS = The Positive and Negative Syndrome Scale. CTQ-SF = Childhood trauma questionnaire short-form. Unstandardized coefficients are reported due to the independent variables being measured in the same metric.

[^3]: *p* \< .05.

[^4]: *p* \< .01.

[^5]: Bonferroni corrected *p* \< .00125.

[^6]: Note. *t*-statistics in parenthesis. *Constant* = The value of the dependent variable holding all predictors constant. *PANSS* = The Positive and Negative Syndrome Scale. *CTQ-SF* = Childhood trauma questionnaire short-form. *DDD* = the assumed average maintenance dose per day for a drug used for its main indication in adults. Unstandardized coefficients are reported due to the independent variables being measured in the same metric.

[^7]: *p* \< .05.

[^8]: *p* \< .01.

[^9]: Bonferroni corrected *p* \< .00125.

[^10]: Note. *t*-statistics in parenthesis. *Constant* = The value of the dependent variable holding all predictors constant. *PANSS* = The Positive and Negative Syndrome Scale. *CTQ-SF* = Childhood trauma questionnaire short-form. *DDD* = the assumed average maintenance dose per day for a drug used for its main indication in adults. Unstandardized coefficients are reported due to the independent variables being measured in the same metric. Years of education is included in the regression models only in domains that did not already have the correction in the cognitive test scoring norms.

[^11]: *p* \< .05.

[^12]: *p* \< .01.

[^13]: Bonferroni corrected *p* \< .00125.
